ஆஸ்திரேலிய வாத நோய் சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆஸ்திரேலிய வாத நோய் சங்கம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆஸ்திரேலிய வாத நோய் சங்கம் Today - Breaking & Trending Today

Shortages of tocilizumab medicines

Shortages of tocilizumab medicines
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Australian Rheumatology Association , Medicine Availability Working Group , Roche Products Pty Limited , Therapeutic Goods Administration , Arthritis Australia , ஆஸ்திரேலிய வாத நோய் சங்கம் , கீல்வாதம் ஆஸ்திரேலியா ,

Immunosuppressants and COVID-19

Immunosuppressants and COVID-19
Immunosuppressant drugs are currently being trialled as a potential COVID-19 treatment. Credit: Shidlovski / iStock / Getty Images Plus
Immunosuppressant drugs commonly used for autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease, might, in principle, increase the risk of severe COVID-19 infection and lower vaccines’ efficacy.
Common cold and other upper respiratory tract infections, for example, can be more common in people taking immunosuppressants.
Yet, some such drugs – glucocorticoids, anti-tumour necrosis factors (anti-TNF) and disease-modifying antirheumatic drugs (DMARDs) – are being trialled as potential COVID-19 therapeutics.
Why does this conflicting dichotomy exist? The answer may lie in the difference between the chronic and acute use of these drugs. ....

Catherine Hill , Australian Rheumatology Association , Global Rheumatology Alliance , Rheumatics Diseases , Rheumatology Alliance , Professor Catherine Hill , Australian Rheumatology , கேத்தரின் மலை , ஆஸ்திரேலிய வாத நோய் சங்கம் , உலகளாவிய வாத நோய் கூட்டணி , வாத நோய் கூட்டணி , ப்ரொஃபெஸர் கேத்தரின் மலை , ஆஸ்திரேலிய வாத நோய் ,